From July 1, 2022 to September 30, 2022, the company has repurchased 0 shares, representing 0% for $0 million. With this, the company has completed the repurchase of 5,300,000 shares, representing 5.43% for $1,127.91 million under the buyback announced on February 7, 2019.
Laboratory Corporation of America Holdings
Equities
LH
US50540R4092
Healthcare Facilities & Services
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
207.9 USD | -0.01% | +3.99% | -8.51% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.51% | 17.49B | |
-14.17% | 85.42B | |
+17.86% | 84.38B | |
+10.92% | 29.39B | |
-2.24% | 16.44B | |
-0.24% | 15.28B | |
-2.64% | 11.71B | |
+1.00% | 12.22B | |
-31.23% | 11.98B | |
+26.71% | 11.64B |
- Stock Market
- Equities
- LH Stock
- News Laboratory Corporation of America Holdings
- Tranche Update on Laboratory Corporation of America Holdings (NYSE: LH)'s Equity Buyback Plan announced on February 7, 2019.